1. John BabbitPartner, Life Sciences,Transaction Advisory ServicesEY 2. ProgressionsNavigating the payer landscapeMEDTECH2014Redefining Innovation in the Face of Healthcare…

1. Research & DevelopmentUpdateJP Morgan Healthcare ConferenceJanuary 7, 2008Elliott Sigal, MD, PhD Executive Vice PresidentChief Scientific Officer & President,…

1. 1 Clinical Pharmacology in SpecialClinical Pharmacology in Special PopulationsPopulations Patty Slattum, PharmD, PhDPatty Slattum, PharmD, PhD March 31, 2014March 31,…

1. WELCOME Accredited Consultants Pvt. Ltd. 29 Acharyaniketan, 1st . Floor, Mayur Vihar Phase 1, New Delhi 91, India. 2. DRUG REGULATORY AFFAIRS Government of India Accredited…

Slide 1Big Pharma and Evidence- Based Medicine: An Oxymoron? Kenneth Brummel-Smith, MD Charlotte Edwards Maguire Professor of Geriatrics Florida State University College…

New Drugs and Patent Losses for 2014/2015 Their Effect on the Pharmacy Buyer Sherrie L. Lane PD Learning Objectives Understand which new drug approvals are targeted for 2014/2015…

D ip lo m at C lin ic al S er vi ce s | S pe ci al ty D ru g A pp ro va ls 1 Specialty Drug Approvals 2014 HIGHLIGHTS + 2015 PROJECTIONS cl inical services INDUSTRY AND MARKET…